Suicidal Thoughts Could Be Linked To Chantix Says FDA

The US Food and Drug Administration (FDA) has issued what the agency terms an “early communication” about a potential, but yet to be confirmed, safety issue with Pfizer’s smoking cessation drug Chantix, where a number of postmarketing cases have reported patients on Chantix experiencing suicidal thoughts and related erratic behaviour. [click link for full article]

More: continued here

Filed under: Smoking / Quit Smoking on December 2nd, 2007